“In people who have diabetes, when they’re on GLP-1s, they experience an early increase in the risk of diabetic retinopathy,” ...

Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonide) delayed release capsules), has been included ...

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Advance Phase 2 Clinical Trial of Dimeric Fc-modified anti-CD40L mAb, TNX-1500, to Prevent Kidney Transplant Organ ...

Trends, Growth Drivers, Challenges, Opportunities, and Competitive Landscape: The artificial sweetener market is experiencing ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes ...